tiprankstipranks
Trending News
More News >
Paramount Bed Holdings Co (JP:7817)
:7817
Advertisement

Paramount Bed Holdings Co (7817) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7817

Paramount Bed Holdings Co

(OTC:7817)

Rating:79Outperform
Price Target:
¥2,950.00
▲(11.28% Upside)
Paramount Bed Holdings Co scores a 79, driven by strong financial performance and a solid valuation profile. The company's operational efficiency and strategic balance sheet management place it well for continued success. Technical indicators support a positive outlook, though careful attention to cash flow volatility is advised.

Paramount Bed Holdings Co (7817) vs. iShares MSCI Japan ETF (EWJ)

Paramount Bed Holdings Co Business Overview & Revenue Model

Company DescriptionParamount Bed Holdings Co., Ltd. is a leading Japanese company specializing in the design, manufacture, and sale of hospital and care facility beds, as well as related healthcare equipment. The company operates primarily in the medical and welfare sectors, providing innovative solutions that enhance patient care and comfort. Paramount Bed Holdings is renowned for its high-quality products that cater to hospitals, nursing homes, and home care settings, addressing a wide range of healthcare needs.
How the Company Makes MoneyParamount Bed Holdings Co. generates revenue primarily through the sale of its hospital and care facility beds, along with other healthcare-related products and equipment. The company's revenue streams include direct sales to medical institutions, care facilities, and individual customers, as well as partnerships with distributors and healthcare providers. By focusing on innovation and quality, Paramount Bed Holdings maintains competitive pricing and strong market presence, contributing to its financial performance. Additionally, the company benefits from its global operations, expanding its market reach and increasing sales across different regions.

Paramount Bed Holdings Co Financial Statement Overview

Summary
Paramount Bed Holdings Co is financially robust, with strong revenue growth and profitability. The company maintains a solid balance sheet with low leverage and high equity, ensuring stability and flexibility. While the cash flow is positive, some volatility in free cash flow growth suggests the need for careful capital management. Overall, the company is well-positioned for continued growth and resilience in the medical instruments and supplies industry.
Income Statement
85
Very Positive
Paramount Bed Holdings Co demonstrates strong financial performance with a consistent growth trajectory. The gross profit margin has improved significantly over the years, indicating efficient cost management. The net profit margin remains robust, though it shows a slight decline in the latest year. Revenue growth is steady, reflecting the company's strong market position. EBIT and EBITDA margins are healthy, suggesting strong operational efficiency.
Balance Sheet
88
Very Positive
The company showcases a strong balance sheet with a low debt-to-equity ratio, indicating conservative financial leverage. The return on equity is impressive, reflecting effective management of shareholder funds. The equity ratio is high, suggesting a solid financial foundation and stability. Overall, the balance sheet supports the company's growth and risk management strategies.
Cash Flow
82
Very Positive
Paramount Bed Holdings Co's cash flow statement reveals a positive trend in operating cash flow, which covers net income well. The free cash flow has shown growth, although it remains somewhat volatile due to fluctuating capital expenditures. Despite this, the company's cash flow position supports its operational needs and investment activities effectively.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue108.58B106.02B99.01B90.35B87.17B
Gross Profit52.56B50.63B47.20B43.03B40.44B
EBITDA24.14B25.38B21.62B19.95B19.20B
Net Income9.08B10.62B9.21B9.09B8.61B
Balance Sheet
Total Assets183.03B180.02B172.29B164.28B154.36B
Cash, Cash Equivalents and Short-Term Investments43.54B46.75B53.23B54.07B48.36B
Total Debt6.80B5.96B5.51B6.13B7.13B
Total Liabilities45.74B44.01B43.60B42.61B40.54B
Stockholders Equity137.28B136.01B128.69B121.67B113.82B
Cash Flow
Free Cash Flow8.09B3.29B5.35B6.30B6.56B
Operating Cash Flow10.45B7.52B9.15B7.82B10.28B
Investing Cash Flow-141.00M-8.40B-6.33B-220.00M-1.54B
Financing Cash Flow-8.80B-5.97B-3.23B-3.37B-3.04B

Paramount Bed Holdings Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2651.00
Price Trends
50DMA
2566.46
Positive
100DMA
2480.86
Positive
200DMA
2531.37
Positive
Market Momentum
MACD
31.71
Negative
RSI
58.32
Neutral
STOCH
82.32
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7817, the sentiment is Positive. The current price of 2651 is above the 20-day moving average (MA) of 2593.75, above the 50-day MA of 2566.46, and above the 200-day MA of 2531.37, indicating a bullish trend. The MACD of 31.71 indicates Negative momentum. The RSI at 58.32 is Neutral, neither overbought nor oversold. The STOCH value of 82.32 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7817.

Paramount Bed Holdings Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥143.13B17.526.38%3.67%2.72%-6.31%
76
Outperform
$185.94B14.3010.03%2.68%7.28%1.72%
75
Outperform
€175.51B34.054.39%2.56%10.98%-76.45%
69
Neutral
¥74.92B93.201.63%1.66%-0.91%-52.71%
65
Neutral
¥341.94B11.51-0.17%2.40%9.60%-10.22%
60
Neutral
¥10.85B124.68
3.83%3.36%-310.49%
57
Neutral
€240.24B41.722.49%2.15%8.83%-40.24%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7817
Paramount Bed Holdings Co
2,642.00
219.84
9.08%
JP:7702
JMS Co., Ltd.
444.00
-49.75
-10.08%
JP:8086
Nipro
1,488.00
238.72
19.11%
JP:7716
Nakanishi
2,030.00
-494.33
-19.58%
JP:3360
Ship Healthcare Holdings
2,167.50
82.86
3.97%
JP:3593
Hogy Medical Co
5,420.00
1,286.94
31.14%

Paramount Bed Holdings Co Corporate Events

Paramount Bed Holdings Reports Q1 Financial Decline but Projects Annual Growth
Jul 30, 2025

Paramount Bed Holdings Co., Ltd. reported a decline in its financial performance for the first quarter of the fiscal year ending March 31, 2026, with net sales decreasing by 3.8% and operating profit dropping by 31.8% compared to the previous year. Despite the downturn, the company maintains a strong equity-to-asset ratio of 76.6%, and it has not revised its earnings forecasts, projecting a moderate growth in net sales and profit for the full fiscal year.

Paramount Bed Holdings Completes Strategic Disposal of Treasury Stock
Jul 25, 2025

Paramount Bed Holdings Co., Ltd. has completed the disposal of treasury stock as restricted stock to its directors and executive officers, a decision approved by the Board of Directors in June 2025. This strategic move involves the allocation of 23,237 shares, valued at approximately 59.4 million yen, and is aimed at aligning the interests of its leadership with the company’s long-term performance, potentially strengthening its market position and stakeholder confidence.

Paramount Bed Holdings Announces Treasury Stock Disposal for Director Incentives
Jun 27, 2025

Paramount Bed Holdings Co., Ltd. announced the disposal of treasury stock as restricted stock to its directors and executive officers, a move aimed at aligning the interests of its management with shareholders and incentivizing long-term corporate growth. This initiative, part of a previously approved compensation plan, underscores the company’s commitment to sustainable value enhancement and strategic alignment with its stakeholders.

Paramount Bed Holdings Proposes Amendments to Strengthen Business and Governance
May 27, 2025

Paramount Bed Holdings Co., Ltd. announced proposed amendments to its Articles of Incorporation, which will be discussed at the upcoming Annual General Meeting of Shareholders. The changes aim to support the company’s business development by expanding the business purposes to include new areas such as communication information processing equipment and medical device programs. Additionally, the company seeks to enhance its corporate governance by increasing the number of Board Members who are Audit and Supervisory Committee Members from five to seven, reflecting its commitment to transparency and sound management.

Paramount Bed Holdings Announces Amendments to Articles of Incorporation
May 26, 2025

Paramount Bed Holdings Co., Ltd. has announced partial amendments to its Articles of Incorporation, with further details to be provided in the English version of the document in the coming weeks. This move may signal strategic adjustments in the company’s governance or operational framework, potentially impacting its market positioning and stakeholder interests.

Paramount Bed Holdings Announces Increased Year-End Dividend
May 26, 2025

Paramount Bed Holdings Co., Ltd. announced a year-end dividend of 49 yen per share for the fiscal year ending March 31, 2025, reflecting a significant increase from the previous year’s 34 yen. This decision aligns with the company’s strategy to balance shareholder returns with internal reserves to strengthen its financial position and support future growth, as outlined in its Medium-term Management Plan.

Paramount Bed Holdings Announces Leadership Changes
May 14, 2025

Paramount Bed Holdings Co., Ltd. announced a change in its Representative Board Member, with Yosuke Kimura set to take over as the new Representative Board Member and Chairperson, effective June 27, 2025. This change is part of a strategic move to revitalize the company and advance its business operations. Additionally, the company has nominated new candidates for Outside Board Members who will serve as Audit and Supervisory Committee Members, pending approval at the upcoming shareholders’ meeting.

Paramount Bed Holdings Co. Revises Dividend Policy to Enhance Shareholder Returns
May 14, 2025

Paramount Bed Holdings Co., Ltd. has announced a revision in its dividend policy, increasing its dividend on equity target from 4.0% to 5.0% starting from the fiscal year ending March 2026. This change is intended to improve shareholder returns and consider capital costs and share price, with the possibility of additional flexible returns based on market conditions.

Paramount Bed Holdings Revises Medium-term Management Plan Amid Challenging Conditions
May 14, 2025

Paramount Bed Holdings Co., Ltd. has revised its medium-term management plan targets for Phase II of ‘Paramount Vision 2030’ due to a challenging business environment. The company has adjusted its sales targets across various sectors, anticipating lower operating profits and EBITDA, while still focusing on expanding its recurring revenue businesses. These changes are driven by rising costs, sluggish domestic demand, and policy trends in key overseas markets, impacting the company’s financial projections and strategic focus.

Paramount Bed Holdings Co. Reports Fiscal Year 2025 Financial Results and Announces New Dividend Policy
May 14, 2025

Paramount Bed Holdings Co. reported a slight increase in net sales for the fiscal year ended March 31, 2025, despite a decline in operating and ordinary profits. The company announced a significant increase in dividends per share, reflecting a new dividend policy aimed at enhancing shareholder returns. This move indicates a strategic focus on maintaining investor confidence amidst fluctuating profits.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 05, 2025